TELA Bio’s management is scheduled to present virtually at the H.C. Wainwright Annual
TELA Bio’s management will also be participating in the
About
Investor Contact
332-895-3230
ir@telabio.com
Source:
2022 GlobeNewswire, Inc., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.72 USD | +1.94% | +6.07% | -28.70% |
04-15 | TELA Bio, Inc. Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR | CI |
03-22 | Piper Sandler Adjusts Price Target on TELA Bio to $12 From $15, Maintains Overweight Rating | MT |
TELA Bio’s management is scheduled to present virtually at the H.C. Wainwright Annual
TELA Bio’s management will also be participating in the
About
Investor Contact
332-895-3230
ir@telabio.com
Source:
2022 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
-28.70% | 116M | |
-3.79% | 184B | |
-0.84% | 108B | |
-3.75% | 67.82B | |
+3.45% | 51.05B | |
+9.04% | 44.67B | |
+3.40% | 41.78B | |
+3.21% | 26.78B | |
+3.66% | 26.59B | |
+15.23% | 25.86B |